Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy.  Yazdani K, Dolguikh K, Zhang W, Shayegi-Nik S, Ly J, Cooper S, et al. (2022)  PLoS ONE 17(3): e0265811...

Hepatitis C diagnosis and treatment in people who use drugs: mind the gap in the linkage to care.  Taibi C, Luzzitelli I, Visco Comandini U, Girardi E, Monacelli G, Rapisarda LM, Garbuglia AR, Minosse C, Guarrasi V, Vincenzi L, Iacomi F, D'O...

Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.  Tatara E, Gutfraind A, Collier NT, Echevarria D, Cotler SJ, Major ME, et al. (2022)  PLoS ONE 17(3): e0264983....

Effectiveness of Interventions for Prevention of Common Infections Among Opioid Users: A Systematic Review of Systematic Reviews.  Puzhko S, Eisenberg MJ, Filion KB, Windle SB, Hébert-Losier A, Gore G, Paraskevopoulos E, Martel MO, Kudrina I...

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users.  Hsu JT, Hsu PI, Shie CB, Chuah SK, Wu IT, Huang WW, Tang SY, Tsai KF, Kuo LF, Ghose S, Hsu JC, Shih CA. ...

Hepatitis C: Standard of Treatment and What to Do for Global Elimination.  Di Marco L, La Mantia C, Di Marco V.  Viruses. 2022 Feb 28;14(3):505. doi: 10.3390/v14030505. PMID: 35336911; PMCID: PMC8954407. https://www.ncbi.nlm.nih.gov/p...